These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36920729)

  • 1. The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma.
    Chan TC; Pan CT; Hsieh HY; Vejvisithsakul PP; Wei RJ; Yeh BW; Wu WJ; Chen LR; Shiao MS; Li CF; Shiue YL
    Cell Oncol (Dordr); 2023 Aug; 46(4):933-951. PubMed ID: 36920729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retraction Note: The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma.
    Chan TC; Pan CT; Hsieh HY; Vejvisithsakul PP; Wei RJ; Yeh BW; Wu WJ; Chen LR; Shiao MS; Li CF; Shiue YL
    Cell Oncol (Dordr); 2024 Oct; ():. PubMed ID: 39419942
    [No Abstract]   [Full Text] [Related]  

  • 3. EMP2 induces cytostasis and apoptosis via the TGFβ/SMAD/SP1 axis and recruitment of P2RX7 in urinary bladder urothelial carcinoma.
    Li CF; Chan TC; Pan CT; Vejvisithsakul PP; Lai JC; Chen SY; Hsu YW; Shiao MS; Shiue YL
    Cell Oncol (Dordr); 2021 Oct; 44(5):1133-1150. PubMed ID: 34339014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gremlin-1: An endogenous BMP antagonist induces epithelial-mesenchymal transition and interferes with redifferentiation in fetal RPE cells with repeated wounds.
    Li D; Yuan D; Shen H; Mao X; Yuan S; Liu Q
    Mol Vis; 2019; 25():625-635. PubMed ID: 31700227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression.
    Ren J; Smid M; Iaria J; Salvatori DCF; van Dam H; Zhu HJ; Martens JWM; Ten Dijke P
    Breast Cancer Res; 2019 Sep; 21(1):109. PubMed ID: 31533776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.
    Liang PI; Wang YH; Wu TF; Wu WR; Liao AC; Shen KH; Hsing CH; Shiue YL; Huang HY; Hsu HP; Chen LT; Lin CY; Tai C; Wu JY; Li CF
    J Clin Pathol; 2013 Jul; 66(7):573-82. PubMed ID: 23539739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLC14A1 prevents oncometabolite accumulation and recruits HDAC1 to transrepress oncometabolite genes in urothelial carcinoma.
    Chan TC; Wu WJ; Li WM; Shiao MS; Shiue YL; Li CF
    Theranostics; 2020; 10(25):11775-11793. PubMed ID: 33052246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGFB1I1 promotes cell proliferation and migration in urothelial carcinoma.
    Liang PI; Wei YC; Chen HD; Ma YC; Ke HL; Chien CC; Chuang HW
    Kaohsiung J Med Sci; 2024 Mar; 40(3):269-279. PubMed ID: 38180299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder.
    Lee YE; Chan TC; Tian YF; Liang PI; Shiue YL; Chen YS; He HL
    Urol Oncol; 2019 May; 37(5):299.e7-299.e18. PubMed ID: 30660494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gremlin1 Delivered by Mesenchymal Stromal Cells Promoted Epithelial-Mesenchymal Transition in Human Esophageal Squamous Cell Carcinoma.
    Hong D; Liu T; Huang W; Liao Y; Wang L; Zhang Z; Chen H; Zhang X; Xiang Q
    Cell Physiol Biochem; 2018; 47(5):1785-1799. PubMed ID: 29953975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
    Di L; Liu LJ; Yan YM; Fu R; Li Y; Xu Y; Cheng YX; Wu ZQ
    J Exp Clin Cancer Res; 2019 Mar; 38(1):134. PubMed ID: 30898152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of miR-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data.
    Wang Y; Jiang Y; Chen L
    J Cell Mol Med; 2020 Dec; 24(23):13824-13836. PubMed ID: 33107676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DHA inhibits Gremlin-1-induced epithelial-to-mesenchymal transition via ERK suppression in human breast cancer cells.
    Sung NJ; Kim NH; Bae NY; Jo HS; Park SA
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32141512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gremlin1 promotes carcinogenesis of glioma in vitro.
    Guan Y; Cheng W; Zou C; Wang T; Cao Z
    Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):244-256. PubMed ID: 27862197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factor YY1 mediates epithelial-mesenchymal transition through the TGFβ signaling pathway in bladder cancer.
    Xia W; Li Y; Wu Z; Wang Y; Xing N; Yang W; Wu S
    Med Oncol; 2020 Sep; 37(10):93. PubMed ID: 32970204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. He-Chan Pian inhibits the metastasis of non-small cell lung cancer via the miR-205-5p-mediated regulation of the GREM1/Rap1 signaling pathway.
    Kan J; Fu B; Zhou R; Zhou D; Huang Y; Zhao H; Zhang Y; Rong Y; Dong J; Xia L; Liu S; Huang Q; Wang N; Ning N; Zhang B; Zhang E
    Phytomedicine; 2022 Jan; 94():153821. PubMed ID: 34752967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGFβ/SMAD Signaling Pathway in Colorectal Cancer Metastasis.
    Hu H; Wang M; Wang H; Liu Z; Guan X; Yang R; Huang R; Tang Q; Zou C; Wang G; Gao X; Wang X
    Cell Physiol Biochem; 2018; 46(5):1895-1906. PubMed ID: 29719292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA SGO1-AS1 inactivates TGFβ signaling by facilitating TGFB1/2 mRNA decay and inhibits gastric carcinoma metastasis.
    Huang D; Zhang K; Zheng W; Zhang R; Chen J; Du N; Xia Y; Long Y; Gu Y; Xu J; Deng M
    J Exp Clin Cancer Res; 2021 Oct; 40(1):342. PubMed ID: 34706749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.
    Li WM; Huang CN; Ke HL; Li CC; Wei YC; Yeh HC; Chang LL; Huang CH; Liang PI; Yeh BW; Chan TC; Li CF; Wu WJ
    Oncotarget; 2016 Nov; 7(47):77777-77792. PubMed ID: 27780919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition.
    Tseng WC; Chuang CW; Yang MH; Pan CC; Tarng DC
    Urol Oncol; 2016 Nov; 34(11):485.e15-485.e24. PubMed ID: 27519276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.